Researchers develop PrecisionView, a handheld AI-powered endomicroscope for real-time, high-resolution cancer diagnostics.
Key Details
- 1PrecisionView combines advanced optics and deep learning to image cellular and vascular structures non-invasively.
- 2Delivers a field of view five times, and depth of field eight times, greater than traditional in vivo microscopy.
- 3Displays real-time images at up to 15 frames per second, enabling clinicians to examine several square centimeters in one scan.
- 4Validated in healthy volunteers and human tissue samples, successfully identifying precancerous and cancerous lesions.
- 5The device is both compact (about the size of a pen) and low-cost (~$3,000), making it suitable for low-resource settings.
- 6Backed by Rice University, MD Anderson Cancer Center, NIH, NCI, and DARPA funding; larger clinical studies pending.
Why It Matters
This technology could significantly improve early cancer detection by making high-resolution microscopy portable, affordable, and usable at the point of care, especially in underserved regions. Integration of AI and hardware design sets a new paradigm for imaging devices in clinical oncology.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.